GlobalFoundries

The margin thesis is delivering on a flat top line: Q1 gross margin expanded 520bps YoY to 27.6% IFRS on just +3% revenue, FY2025 swung from a $(214)M operating loss to $797M of operating profit, and the company now pays a dividend with an up-to-50%-of-FCF return framework. The silicon-photonics franchise is converting into hard external validation — a $300M CHIPS letter of intent and the SCALE co-packaged-optics platform — while the stock sits 46% below its high with ~$2.65B of net cash.

• Q1 2026 IFRS gross margin 27.6% (+520bps YoY) and non-IFRS 29.0% (+510bps) on only +3% revenue growth — margin, not volume, is doing the work and it is working
• Every non-IFRS profitability metric in Q1 came in at or above the HIGH end of guidance, per management, with non-IFRS diluted EPS $0.40 against a $0.35 +/- $0.05 guide
• FY2025 was a genuine turn: operating profit $797M vs $(214)M in FY2024, net income $888M vs $(262)M, diluted EPS $1.59 vs $(0.48)
• Q2 guidance implies sequential recovery off the Q1 trough: $1,760M revenue (+7.7% QoQ) with non-IFRS gross margin 28.5% and non-IFRS EPS $0.43
• First-ever dividend ($0.12/quarter, first paid 2026-07-14) plus a framework returning up to 50% of trailing-twelve-month non-IFRS adjusted free cash flow — a capital-discipline signal from a company that was loss-making two years ago
• $300M CHIPS letter of intent (2026-07-29) funds next-generation silicon-photonics wafer technologies, optical materials and advanced packaging including 3D hybrid bonding, at Malta N.Y. and Burlington Vt. — third-party validation of the AI-interconnect position
• SCALE, the first OCI MSA-tailored co-packaged-optics module platform, targets 400Gb/s and a 5x energy-efficiency improvement — a specific, testable spec rather than a roadmap slide
• Renesas expanded multi-billion-dollar partnership means GF now manufactures for the top three automotive MCU makers globally — durable, long-cycle essential-chip demand
• Cash generation is real: FY2025 operating cash flow $1,731M and non-IFRS adjusted FCF $1,157M (17% margin); Q1 2026 adjusted FCF margin rose to 14.3% from 10.4% even as capex nearly doubled
• Balance sheet: ~$2.65B net cash ($3.8B liquidity vs $1,147M debt) funds the investment year without external financing
• Valuation reset: $50.01 (2026-08-03) is ~46% below the $92.55 52-week high

Start with what this refresh actually found: the filing that flagged the dossier stale carried no financials at all — it was AGM voting results and a director resignation. So the newest numbers are a quarter old, and the Q2 print lands 2026-08-05. Behind that, revenue has been flat for two years (+1% FY2025, +3% YoY in Q1), FY2025 adjusted EBITDA actually FELL 5% with margin down 200bps despite 10% more wafers, capex intensity is roughly doubling to ~19%, the $300M award is a letter of intent that costs ~1% of the equity to the U.S. government, and the board just shrank by two.

• The staleness trigger was not results: the 2026-07-29 6-K reports the 2026-07-28 AGM votes plus Elissa Murphy's resignation and Martin Edelman's non-re-election. Any figure here is Q1 2026 vintage and is one day from being superseded by the 2026-08-05 Q2 print
• Revenue is structurally flat: +1% FY2025 ($6,791M vs $6,750M), +3% YoY in Q1 2026, and -11% sequentially. The whole equity case rests on margin expansion off a stagnant base
• FY2025 non-IFRS adjusted EBITDA FELL 5% to $2,357M with margin down 200bps to 34.7% — while wafer shipments rose 10% to 2,345k. More units, less EBITDA: ASP and mix are working against the volume
• Capex intensity is roughly doubling — 19.1% of revenue in Q1 2026 versus ~8.5% for FY2025 — so free cash flow gets compressed for several quarters before any of the new capacity earns a return
• The $300M CHIPS award is a LETTER OF INTENT, not a definitive agreement, and the consideration is equity: the Department of Commerce receives approximately 1% ownership. A sovereign on the register is a new governance variable, and the press release makes no statement about dilution mechanics
• Governance friction at the AGM: the board shrank from thirteen to eleven directors, and Carlos Obeid drew only 82.35% support against 99.53% and 94.44% for the other two nominees
• The IFRS-to-non-IFRS gap is wide and widening: Q1 non-IFRS operating margin 16.6% vs 11.0% IFRS (a 560bps bridge), driven substantially by share-based compensation that rose to $63M from $40M a year earlier
• IFRS earnings went backwards: Q1 2026 net income $104M (-51% YoY) and diluted EPS $0.18 vs $0.38 — flattered in the prior year by a tax benefit, but still the GAAP-equivalent direction of travel
• Liquidity is drifting down: $3.8B of cash and marketable securities at 2026-03-31 versus $4.0B at 2025-12-31, and the company simultaneously started paying a dividend into an investment year
• The market de-rated ahead of the print: $59.39 (2026-07-21) -> $47.07 (2026-07-29) -> $50.01 (2026-08-03), -46% from the 52-week high, so the Q2 beat that guidance implies may already be priced as insufficient
• Mubadala's majority ownership limits float and leaves a controlling shareholder whose strategic interests need not align with minority holders
• Q1 wafer shipments fell 6% sequentially to 579k, so the Q2 revenue recovery to $1,760M depends on both volume and price recovering together